Scholars Central

Conference abstractPublished 17 Jul 2017

Emap-II-induced immune suppression in colorectal cancer

Authors: Manal Mohamed Saber, Matthias Clauss

Minia University, Egypt; Indiana University School of Medicine, Indianapolis, Indiana

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: Colorectal cancer (CRC) is being currently considered one of the most common and deadly malignancies in the world. Many CRC patients are likely to be immunosuppressive. Endothelial monocyte-activating polypeptide-II (EMAP-II) is a multifunctional cytokine with pro-inflammatory properties. It was demonstrated that EMAP-II induces lymphocytes apoptosis in CRC. The purpose of this study is to investigate the role of EMAP II in immune suppression in CRC. Methodology & Theoretical Orientation: The immunosuppressive effect of EMAP-II was verified by in vivo and in vitro experiments. The immunosuppressive mechanisms were analysed using flow cytometry, ELISA, immunohistochemistry and T-lymphocytes assays. Findings: EMAP-II expression in CRC was associated with suppression of T-cell activity and decreased infiltrating T-cells. EMAP-II blockade in mice bearing colorectal cancer reduced tumour burden and increased T-cell responses. In this study, we found that colorectal cancer-infiltrating tregs expressed increased levels of EMAP-II. Furthermore, EMAP-II levels correlated positively with serum IL-2 and TGF-Ã?² (p<0.001). Conclusion & Significance: This study has demonstrated the role of EMAP-II in immune suppression and the potential for immunotherapy via blocking EMAP-II in CRC.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Immunotherapy: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalImmunotherapy: Open Access
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Manal Mohamed Saber”
  • BylineArticles whose byline prints “Matthias Clauss”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels